Huntington National Bank’s Albany Molecular Research Inc AMRI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$22 Hold
1
﹤0.01% 3426
2025
Q4
$22 Hold
1
﹤0.01% 3342
2025
Q3
$22 Hold
1
﹤0.01% 3399
2025
Q2
$22 Hold
1
﹤0.01% 3414
2025
Q1
$22 Hold
1
﹤0.01% 3434
2024
Q4
$22 Hold
1
﹤0.01% 3448
2024
Q3
$22 Hold
1
﹤0.01% 3440
2024
Q2
$22 Hold
1
﹤0.01% 3397
2024
Q1
$22 Hold
1
﹤0.01% 3257
2023
Q4
$22 Hold
1
﹤0.01% 3160
2023
Q3
$22 Hold
1
﹤0.01% 3134
2023
Q2
$22 Hold
1
﹤0.01% 3103
2023
Q1
$22 Hold
1
﹤0.01% 2949
2022
Q4
$22 Hold
1
﹤0.01% 2816
2022
Q3
$0 Hold
1
﹤0.01% 2666
2022
Q2
$0 Hold
1
﹤0.01% 2669
2022
Q1
$0 Hold
1
﹤0.01% 2596
2021
Q4
$0 Hold
1
﹤0.01% 2523
2021
Q3
$0 Hold
1
﹤0.01% 2249
2021
Q2
$0 Hold
1
﹤0.01% 2138
2021
Q1
$0 Hold
1
﹤0.01% 2028
2020
Q4
$0 Hold
1
﹤0.01% 2005
2020
Q3
$0 Hold
1
﹤0.01% 1951
2020
Q2
$0 Hold
1
﹤0.01% 1965
2020
Q1
$0 Hold
1
﹤0.01% 2059
2019
Q4
$0 Hold
1
﹤0.01% 2072
2019
Q3
$0 Hold
1
﹤0.01% 1977
2019
Q2
$0 Buy
+1
New ﹤0.01% 2008
2019
Q1
Sell
-1
Closed 2003
2018
Q4
$0 Hold
1
﹤0.01% 2065
2018
Q3
$0 Buy
+1
New ﹤0.01% 2049

Huntington National Bank's AMRI Position: Q1 2026 in Review

Huntington National Bank held its Albany Molecular Research Inc (AMRI) position steady in Q1 2026 at 1 share worth $22. The position accounts for ﹤0.01% of the portfolio, ranked #3426.

Huntington National Bank first reported a position in AMRI in Q3 2018 and has held it in 30 quarters since. 1 fund tracked by Wall St. Rank holds AMRI as of Q1 2026.

  • Huntington National Bank held 1 share of Albany Molecular Research Inc worth $22 as of Q1 2026.
  • Huntington National Bank left its Albany Molecular Research Inc share count unchanged in Q1 2026.
  • Albany Molecular Research Inc made up ﹤0.01% of Huntington National Bank's portfolio in Q1 2026, its #3426 holding.
  • Huntington National Bank first reported a position in Albany Molecular Research Inc in Q3 2018 and has held it in 30 quarters since.
  • 1 fund tracked by Wall St. Rank held Albany Molecular Research Inc as of Q1 2026.

Based on Huntington National Bank's 13F filing for Q1 2026, filed 15 May 2026.